Trials / Unknown
UnknownNCT03648645
Hypertensive Pregnant Women Monitored by Teletransmitted Self-measurements of Blood Pressure
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Rennes University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The occurrence of arterial hypertension (AH) during pregnancy is a major cause of fetal, neonatal and maternal morbidity and mortality in western countries. It is estimated that about 10% of pregnancies are complicated by AH (80 000 women / year in France). It is therefore essential to diagnose AH with certainty in order to set-up appropriate care and follow its evolution.
Detailed description
The objective of this study is to show the faisability of self-measurement with teletransmission for long-term follow-up of hypertensive pregnant women (at high risk of preeclampsia) by avoiding repeated, prolonged visits or hospitalizations and to optimize the intervention of health professionals by providing them with reliable data. A multicenter, controlled study will be conducted in women presenting with mild to moderate hypertension without preeclampsia followed throughout their pregnancy by either self-measurement with teletransmission.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Self measurement of blood pressure | Patients will perform the measurement of blood pressure at home, on a daily basis, in complying with the "rule of 3" stated by the Haute Autorité de Santé (French Health Authority) : i.e. 3 consecutive measurements in the morning and in the evening, after a period of rest Measurements are performed using a blood pressure monitor Bluetooth-connected. If a threshold value is exceeded (and depending on the alert), a consultation will be scheduled (unexpected consultation) and notified to the patient. |
Timeline
- Start date
- 2022-05-25
- Primary completion
- 2023-11-01
- Completion
- 2023-11-01
- First posted
- 2018-08-27
- Last updated
- 2023-07-28
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03648645. Inclusion in this directory is not an endorsement.